157 related articles for article (PubMed ID: 17972276)
1. The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls.
Palmer C; Ellis KA; O'Neill BV; Croft RJ; Leung S; Oliver C; Wesnes KA; Nathan PJ
Hum Psychopharmacol; 2008 Mar; 23(2):151-9. PubMed ID: 17972276
[TBL] [Abstract][Full Text] [Related]
2. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
3. High-dose glycine impairs the prepulse inhibition measure of sensorimotor gating in humans.
O'Neill BV; Croft RJ; Mann C; Dang O; Leung S; Galloway MP; Phan KL; Nathan PJ
J Psychopharmacol; 2011 Dec; 25(12):1632-8. PubMed ID: 20615931
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
Kennedy DO; Jackson PA; Haskell CF; Scholey AB
Hum Psychopharmacol; 2007 Dec; 22(8):559-66. PubMed ID: 17902186
[TBL] [Abstract][Full Text] [Related]
5. Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine.
Kennedy DO; Haskell CF; Mauri PL; Scholey AB
Hum Psychopharmacol; 2007 Jun; 22(4):199-210. PubMed ID: 17457961
[TBL] [Abstract][Full Text] [Related]
6. The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects.
Liem-Moolenaar M; Zoethout RW; de Boer P; Schmidt M; de Kam ML; Cohen AF; Franson KL; van Gerven JM
J Psychopharmacol; 2010 Nov; 24(11):1681-7. PubMed ID: 19648218
[TBL] [Abstract][Full Text] [Related]
7. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
[TBL] [Abstract][Full Text] [Related]
8. D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.
Matsuoka N; Aigner TG
J Pharmacol Exp Ther; 1996 Aug; 278(2):891-7. PubMed ID: 8768744
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
10. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
Lofwall MR; Griffiths RR; Mintzer MZ
Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
[TBL] [Abstract][Full Text] [Related]
11. The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects.
Liem-Moolenaar M; Zoethout RW; de Boer P; Schmidt M; de Kam ML; Cohen AF; Franson KL; van Gerven JM
J Psychopharmacol; 2010 Nov; 24(11):1671-9. PubMed ID: 20142308
[TBL] [Abstract][Full Text] [Related]
12. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.
Wesnes KA; Edgar C; Tretter RN; Bolodeoku J
Expert Opin Drug Saf; 2009 Nov; 8(6):615-26. PubMed ID: 19747069
[TBL] [Abstract][Full Text] [Related]
13. Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls.
Leung S; Croft RJ; O'Neill BV; Nathan PJ
Psychopharmacology (Berl); 2008 Feb; 196(3):451-60. PubMed ID: 17952411
[TBL] [Abstract][Full Text] [Related]
14. Effects of pharmacologically induced changes in NMDA receptor activity on human timing and sensorimotor performance.
Rammsayer TH
Brain Res; 2006 Feb; 1073-1074():407-16. PubMed ID: 16423331
[TBL] [Abstract][Full Text] [Related]
15. The effects of L-theanine, caffeine and their combination on cognition and mood.
Haskell CF; Kennedy DO; Milne AL; Wesnes KA; Scholey AB
Biol Psychol; 2008 Feb; 77(2):113-22. PubMed ID: 18006208
[TBL] [Abstract][Full Text] [Related]
16. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam.
Snyder PJ; Werth J; Giordani B; Caveney AF; Feltner D; Maruff P
Hum Psychopharmacol; 2005 Jun; 20(4):263-73. PubMed ID: 15912482
[TBL] [Abstract][Full Text] [Related]
17. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
Hallam KT; Olver JS; McGrath C; Norman TR
Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
[TBL] [Abstract][Full Text] [Related]
18. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers.
Tildesley NT; Kennedy DO; Perry EK; Ballard CG; Wesnes KA; Scholey AB
Physiol Behav; 2005 Jan; 83(5):699-709. PubMed ID: 15639154
[TBL] [Abstract][Full Text] [Related]
19. Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers.
Poirier MF; Galinowski A; Amado I; Longevialle R; Bourdel MC; Tournoux A; Serre C; Loo H
Hum Psychopharmacol; 2004 Jan; 19(1):1-7. PubMed ID: 14716705
[TBL] [Abstract][Full Text] [Related]
20. Elevated T-maze evaluation of anxiety and memory effects of NMDA/glycine-B site ligands injected into the dorsal periaqueductal gray matter and the superior colliculus of rats.
Santos P; Bittencourt AS; Schenberg LC; Carobrez AP
Neuropharmacology; 2006 Aug; 51(2):203-12. PubMed ID: 16697017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
